Explore / Clinical trial
Clinical trial

A 12 -Month, Open-label, Multi-center Study to Explore the Health Outcomes of FTY720

Novartis PharmaceuticalsCompletedPhase 4Started Oct 1, 201242 enrolledTurkey (Türkiye)NCT01578330

Abstract

The study will assess the patients' satisfaction of treatment after 12 months treatment with fingolimod It also will assess the tolerability profile of fingolimod in a small population.

Keywords

Relapsing remitting multiple sclerosisFingolimodFTY720Multiple SclerosisRelapsing-Remitting

Psychedelic Commons aggregates metadata from open sources and links back to the original. Rights remain with the authors and publishers. Something wrong with this record? Report a problem.